Cargando…

Long-term outcome of tyrosine kinase inhibitor treatment in children and adolescents with newly diagnosed chronic myeloid leukemia in chronic phase

Detalles Bibliográficos
Autores principales: Zheng, Yong-Zhi, Li, Jian, Chen, Cai, Zheng, Hao, Fu, Dan-Hui, Hu, Jian-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710332/
https://www.ncbi.nlm.nih.gov/pubmed/34310396
http://dx.doi.org/10.1097/CM9.0000000000001656
_version_ 1784623128820842496
author Zheng, Yong-Zhi
Li, Jian
Chen, Cai
Zheng, Hao
Fu, Dan-Hui
Hu, Jian-Da
author_facet Zheng, Yong-Zhi
Li, Jian
Chen, Cai
Zheng, Hao
Fu, Dan-Hui
Hu, Jian-Da
author_sort Zheng, Yong-Zhi
collection PubMed
description
format Online
Article
Text
id pubmed-8710332
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-87103322021-12-28 Long-term outcome of tyrosine kinase inhibitor treatment in children and adolescents with newly diagnosed chronic myeloid leukemia in chronic phase Zheng, Yong-Zhi Li, Jian Chen, Cai Zheng, Hao Fu, Dan-Hui Hu, Jian-Da Chin Med J (Engl) Clinical Observation Lippincott Williams & Wilkins 2021-12-20 2021-07-22 /pmc/articles/PMC8710332/ /pubmed/34310396 http://dx.doi.org/10.1097/CM9.0000000000001656 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Clinical Observation
Zheng, Yong-Zhi
Li, Jian
Chen, Cai
Zheng, Hao
Fu, Dan-Hui
Hu, Jian-Da
Long-term outcome of tyrosine kinase inhibitor treatment in children and adolescents with newly diagnosed chronic myeloid leukemia in chronic phase
title Long-term outcome of tyrosine kinase inhibitor treatment in children and adolescents with newly diagnosed chronic myeloid leukemia in chronic phase
title_full Long-term outcome of tyrosine kinase inhibitor treatment in children and adolescents with newly diagnosed chronic myeloid leukemia in chronic phase
title_fullStr Long-term outcome of tyrosine kinase inhibitor treatment in children and adolescents with newly diagnosed chronic myeloid leukemia in chronic phase
title_full_unstemmed Long-term outcome of tyrosine kinase inhibitor treatment in children and adolescents with newly diagnosed chronic myeloid leukemia in chronic phase
title_short Long-term outcome of tyrosine kinase inhibitor treatment in children and adolescents with newly diagnosed chronic myeloid leukemia in chronic phase
title_sort long-term outcome of tyrosine kinase inhibitor treatment in children and adolescents with newly diagnosed chronic myeloid leukemia in chronic phase
topic Clinical Observation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710332/
https://www.ncbi.nlm.nih.gov/pubmed/34310396
http://dx.doi.org/10.1097/CM9.0000000000001656
work_keys_str_mv AT zhengyongzhi longtermoutcomeoftyrosinekinaseinhibitortreatmentinchildrenandadolescentswithnewlydiagnosedchronicmyeloidleukemiainchronicphase
AT lijian longtermoutcomeoftyrosinekinaseinhibitortreatmentinchildrenandadolescentswithnewlydiagnosedchronicmyeloidleukemiainchronicphase
AT chencai longtermoutcomeoftyrosinekinaseinhibitortreatmentinchildrenandadolescentswithnewlydiagnosedchronicmyeloidleukemiainchronicphase
AT zhenghao longtermoutcomeoftyrosinekinaseinhibitortreatmentinchildrenandadolescentswithnewlydiagnosedchronicmyeloidleukemiainchronicphase
AT fudanhui longtermoutcomeoftyrosinekinaseinhibitortreatmentinchildrenandadolescentswithnewlydiagnosedchronicmyeloidleukemiainchronicphase
AT hujianda longtermoutcomeoftyrosinekinaseinhibitortreatmentinchildrenandadolescentswithnewlydiagnosedchronicmyeloidleukemiainchronicphase